The White House’s vision for a radical overhaul of federal health spending met a familiar wall of institutional resistance this week. During a Senate appropriations subcommittee hearing on Tuesday, Health and Human Services Secretary Robert F. Kennedy Jr. faced a skeptical bipartisan front as he defended a 2027 fiscal budget that proposes a 12% reduction in departmental funding. The plan, which mirrors previous attempts to scale back the federal scientific apparatus, seeks to consolidate power and pivot resources away from established research frameworks.
At the heart of the administration’s proposal is a deep retrenchment of the National Institutes of Health (NIH) and the elimination of a health research agency. In their place, the administration envisions the "Administration for a Healthy America," a new body specifically tasked with addressing chronic disease, smoking cessation, and cancer. However, lawmakers questioned the logic of tackling these systemic health crises while simultaneously withdrawing the financial support required for the basic science that makes such progress possible.
This friction suggests that for the second consecutive year, Congress is likely to bypass the administration’s most drastic proposals in favor of a more stable funding package. While the White House frames these cuts as a necessary reorganization to prioritize public health outcomes, senators from both parties appear wary of dismantling the research infrastructure that has long defined the American lead in biotechnology. The standoff highlights an enduring tension between a disruptive executive branch and a legislature committed to the steady, if slower, pace of institutional continuity.
With reporting from STAT News (Biotech).
Source · STAT News (Biotech)
